Previous Statements by MYGN
» Myriad Genetics Inc. F2Q10 Earnings Conference Call
» Myriad Genetics, Inc F4Q09 (Qtr End 06/30/09) Earnings Call Transcript
» Myriad Genetics F3Q09 (Qtr End 03/31/09) Earnings Call Transcript
Jefferies lowered its price target to $20 on Myriad Genetics (MYGN) stock this morning saying that 'hereditary cancer cracks are emerging.'
Here's a technical look at how to trade some of the most active stocks on the market right now.